Biophage Pharma Overview
- Founded
-
1995
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Biophage Pharma General Information
Description
Developer of phage-based biotechnology product. The company is focused on the development of phage-based technologies for the detection and management of pathogenic bacteria. It operates two divisions: a therapeutic division involved in the management of bacterial contaminations in the medical, veterinary and environmental; and a biosensors division dedicated to the development and commercialization of novel biosensors.
Contact Information
Formerly Known As
Almont Capital
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Acquirer
Phagelux Canada
Primary Office
- 6100 Royalmount
- Montreal, Quebec H4P 2R2
- Canada
Biophage Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biophage Pharma Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Theodore Rousseau | Chief Executive Officer |